Meropenem - Pfizer/Sumitomo Pharma
At a glance
- Drug Originator Dainippon Sumitomo Pharma
- Drug Licenced by BDI Pharma; Pfizer; Sanofi
- Drug Class Antibacterials; Pyrrolidines; Small molecules; Thienamycins
- Mechanism of Action Cell wall inhibitors
- USA Patent Applicants PFIZER
- USA Patents 1
- NDAs 1
- Patent Applications 5,579
Table of Contents

Disclaimer